๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Interferon alpha-2a and 5-fluorouracil for advanced colorectal carcinoma assessment of activity and toxicity

โœ Scribed by Nancy Kemeny; Anas Younes; Karen Seiter; David Kelsen; Patricia Sammarco; Lynn Adams; Susan Derby; Peggy Murray; Collette Houston

Publisher
John Wiley and Sons
Year
1990
Tongue
English
Weight
621 KB
Volume
66
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

5-fluorouracil and interferon-alpha-2a i
5-fluorouracil and interferon-alpha-2a in advanced colorectal cancer. Results of two treatment schedules
โœ William J. John; John R. Neefe; John S. Macdonald; Jim Cantrell Jr.; Marietta Sm ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 505 KB

Background. Potential synergy between 5-fluorouracil (5-FU) and interferon alpha-2a (IFN-a-Za) has been demonstrated in the treatment of colorectal carcinoma. Continuous low-dose infusion of 5-FU may have superior response rates to bolus 5-FU in these malignancies. This report presents results of tw

Bimonthly high dose leucovorin and 5-flu
Bimonthly high dose leucovorin and 5-fluorouracil 48-hour infusion with interferon-alpha-2a in patients with advanced colorectal carcinoma
โœ Christophe Tournigand; Christophe Louvet; Aimery de Gramont; Elisabeth Lucchi; J ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 88 KB ๐Ÿ‘ 2 views

disease progression. IFN was administered subcutaneously three times weekly at for the Groupe d'Etude et de a dose of 3 MU (body surface area [BSA] รต 1.75 m 2 ) or 4.5 MU (BSA ยข 1.75 m 2 ). Recherche sur les Cancers de RESULTS. World Health Organization toxicity Grade 3-4 occurred in 21 patients l'O